Doesn't change the fact it's cheap, fast, and accurate for detecting immune response which will become more relevant down the track IMO. Also, I'd expect loads of places are simply not going to be able to set up and operate labs for molecular testing on the required scale or timeframe.
- Forums
- ASX - By Stock
- 50% margin ? The product
Doesn't change the fact it's cheap, fast, and accurate...
-
- There are more pages in this discussion • 80 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
|
|||||
Last
2.2¢ |
Change
0.002(10.0%) |
Mkt cap ! $12.78M |
Open | High | Low | Value | Volume |
2.0¢ | 2.2¢ | 2.0¢ | $1.269K | 60.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1535 | 2.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.2¢ | 1764 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1535 | 0.021 |
10 | 1605509 | 0.020 |
3 | 695000 | 0.019 |
3 | 162414 | 0.018 |
3 | 65000 | 0.017 |
Price($) | Vol. | No. |
---|---|---|
0.022 | 1764 | 1 |
0.023 | 51275 | 1 |
0.024 | 535043 | 6 |
0.025 | 49000 | 2 |
0.026 | 1115954 | 4 |
Last trade - 12.38pm 04/09/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |